Apellis Pharmaceuticals, Inc.
Industry: Life Sciences ・ $APLS on Nasdaq
Insider Sale
+$37,001
-1.41%
Shares
Shares Volume: 1,235 Shares
Average Share Price: $29.96
INSIDER
DeLong Mark Jeffrey
Chief Business & Strat Officer (Officer)
reported on Jan 21 2025
traded on Jan 17 2025
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 86,069 |
| PURCHASES/SALES 1Y | 0 / 5 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $47,369.99 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 11 |
| PURCHASES/SALES 1Y | 0 / 53 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $406,881.56 |
| COMPANY PREVIOUS TRADES |